Working… Menu

A Study of the Safety and Tolerance of Three Doses of G17DT in Metastatic Colorectal Cancer (CC1C)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02228785
Recruitment Status : Terminated (Poor local tolerance to injection.)
First Posted : August 29, 2014
Last Update Posted : August 29, 2014
Information provided by (Responsible Party):
Cancer Advances Inc.

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : October 1994
Study Completion Date : No date given